Tech Company Financing Transactions
Caris Life Sciences Funding Round
Braidwell and OrbiMed participated in a $400 million funding round for Caris Life Sciences. The round was announced on 1/19/2023.
Transaction Overview
Company Name
Announced On
1/19/2023
Transaction Type
Debt
Amount
$400,000,000
Round
Undisclosed
Proceeds Purpose
Caris will use the proceeds to repay outstanding debt, enhance its pioneering precision medicine platform, and for general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
750 West John Carpenter Freeway 800
Irving, TX 75039
USA
Irving, TX 75039
USA
Phone
Website
Email Address
Overview
Caris Life Sciences was founded with a very simple but powerful purpose -- to help improve the lives of as many people as possible. With transformative technologies, we are revolutionizing precision medicine to provide physicians and patients with the highest quality information about their health.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 1/19/2023: Knownwell venture capital transaction
Next: 1/19/2023: Aikido Security venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs